Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Cancer Vaccines01:30

Cancer Vaccines

871
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
871
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Food allergy severity across the world: A World Allergy Organization international survey.

The World Allergy Organization journal·2025
Same author

Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies.

The Journal of allergy and clinical immunology·2025
Same author

The noncoding circular RNA <i>circHomer1</i> regulates synaptic development and experience-dependent plasticity in the mouse visual cortex.

iScience·2025
Same author

From the pages of AllergyWatch.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

From the pages of AllergyWatch.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

Introduction of allergenic foods after treatment with omalizumab.

The Journal of allergy and clinical immunology·2025

Related Experiment Video

Updated: Dec 23, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.1K

Peanut Oral Immunotherapy: a Current Perspective.

Meera Patrawala1,2, Jennifer Shih3,4, Gerald Lee3,4

  • 1Emory University School of Medicine, 1400 Tullie Road NE 5th floor, Atlanta, GA, 30329, USA. meera.mehta@emory.edu.

Current Allergy and Asthma Reports
|April 22, 2020
PubMed
Summary
This summary is machine-generated.

Peanut oral immunotherapy (OIT) shows promise for desensitizing patients with peanut allergy, with many achieving treatment goals. However, potential risks and side effects require further investigation for real-world application.

Keywords:
DesensitizationFood allergyOral food challengeOral immunotherapyPeanut allergySustained unresponsiveness

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.7K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.4K

Related Experiment Videos

Last Updated: Dec 23, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.1K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.7K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.4K

Area of Science:

  • Allergy and Immunology
  • Clinical Therapeutics
  • Food Science

Background:

  • Peanut allergy is a significant health concern.
  • Peanut oral immunotherapy (OIT) is an emerging treatment strategy.
  • The recent FDA approval of Palforzia highlights advancements in OIT.

Purpose of the Study:

  • To review recent clinical trial data on peanut OIT.
  • To discuss current trends in peanut OIT research.
  • To anticipate future developments in peanut allergy treatment.

Main Methods:

  • Review of recent clinical trial data.
  • Analysis of current trends in OIT research.
  • Forecasting future research directions.

Main Results:

  • Peanut OIT demonstrates efficacy in desensitizing a majority of participants.
  • Sustained unresponsiveness is achievable in select patient groups.
  • Improvements in quality of life were observed, but risks like severe allergic reactions exist.

Conclusions:

  • Peanut OIT is a promising therapy for peanut allergy, offering desensitization.
  • Further research is needed to assess long-term effectiveness, real-world outcomes, and risk mitigation strategies.
  • Adjunctive therapies may be explored to enhance OIT safety and efficacy.